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ABSTRACT
Motivation: Deep sequencing based ribosome footprint profiling can
provide novel insights into the regulatory mechanisms of protein
translation. However, the observed ribosome profile is fundamentally
confounded by transcriptional activity. In order to decipher principles
of translation regulation, tools that can reliably detect changes in
translation efficiency in case-control studies are needed.
Results: We present a statistical framework and an analysis tool,
RiboDiff, to detect genes with changes in translation efficiency
across experimental treatments. RiboDiff uses generalized linear
models to estimate the over-dispersion of RNA-Seq and ribosome
profiling measurements separately, and performs a statistical test for
differential translation efficiency using both mRNA abundance and
ribosome occupancy.
Availability: RiboDiff webpage http://bioweb.me/ribodiff.
Source code including scripts for preprocessing the FASTQ data are
available at http://github.com/ratschlab/ribodiff.
Contact: zhongy@cbio.mskcc.org and gunnar@ratschlab.org.
1 INTRODUCTION
The recently described ribosome footprinting technology (Ingolia
et al., 2012) allows the identification of mRNA fragments that were
protected by the ribosome. It provides valuable information on
ribosome occupancy and, thereby indirectly, on protein synthesis
activity. This technology can be leveraged by combining the
measurements from RNA-Seq estimates in order to determine
a gene’s translation efficiency (TE), which is the ratio of the
abundances of translated mRNA and available mRNA (Ingolia et al.,
2011). The normalization by mRNA abundance is designed to
remove transcriptional activity as a confounder of RF abundance.
The TEs in treatment/control experiments can then be compared
to identify genes most affected w.r.t. translation efficiency. For
instance, Thoreen et al. (2012) considered a ratio (fold-change)
of the TEs of treatment and control. However, what these initial
approaches only take into account partially is that one typically only
obtains uncertain estimates of the mRNA and ribosome abundance.
In particular for lowly expressed genes, the error bars for the ratio
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of two TE values can be large. As in proper RNA-Seq analyses, one
should consider the uncertainty in these abundance measurements
when testing for differential abundance. For RNA-Seq, this has
been described in various ways often based on generalized linear
models taking advantage of dispersion information from biological
replicates (Robinson et al., 2010; Anders et al., 2012; Drewe et al.,
2013). In Wolfe et al. (2014) and Zhong et al. (2015), a way to adopt
an approach for RNA-Seq analysis for this problem was described
that had several conceptual and practical limitations. Here, we
describe a novel statistical framework that also uses a generalized
linear model to detect effects of a particular treatment on mRNA
translation. Additionally, our approach accounts for the fact that two
different sequencing protocols with distinct statistical characteristics
are used. We compare it to the Z-score based approach (Thoreen
et al., 2012), DESeq2 (Love et al., 2014) and a recently published
tool Babel (Olshen et al., 2013) that is based on errors-in-variables
regression. Shell and Python scripts for trimming RF adaptor,
aligning reads, removing rRNA contamination and counting reads
are also included in the RiboDiff package.
2 METHODS
In sequencing-based ribosome footprinting, the RF read count is naturally
confounded by mRNA abundance (Fig. 1A). We seek a strategy to compare
RF measurements taking mRNA abundance into account in order to
accurately discern the translation effect in case-control experiments. We
model the vector of RNA-Seq and RF read counts yi
mRNA
and yi
RF
,
respectively, for gene i with Negative Binomial (NB) distributions, as
described before (for instance, Robinson et al., 2010; Love et al., 2014;
Drewe et al., 2013): yi ∼ NB(µi, κi),where µi is the expected count and
κi is the estimated dispersion across biological replicates. Here yi denotes
the observed counts normalized by the library size factor (Supplemental
Section A). Formulating the problem as a generalized linear model (GLM)
with the logarithm as link function, we can express expectations on read
counts as a function of latent quantities related to mRNA abundance βC
in the two conditions (C = {0, 1}), a quantity βRNA that relates mRNA
abundance to RNA-Seq read counts, a quantity βRF that relates mRNA
abundance to RF read counts and a quantity β∆,C that captures the effect
of the treatment on translation. In particular, the expected RNA-Seq read
count µi
mRNA,C is given by the equation log(µ
i
mRNA,C) = β
i
C+β
i
RNA.
We assume that transcription and translation are successive cellular
processing steps and that abundances are linearly related. The expected RF
read count, µi
RF,C , is given by log(µ
i
RF,C) = β
i
C + β
i
RF + β
i
∆,C . A
key point to note is that βiC is revealed to be a shared parameter between
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Fig. 1. (A) Graphical model representing RidoDiff (Gray circle: observable variables; empty circle: unobservable variables; black square: functions; r denotes
biological replicates; i denotes a gene and G is the number of genes). The dashed line denotes the relationship that we aim to test (see Methods for details).
(B) Receiver operating characteristic (ROC) curve of RiboDiff (with separate dispersions), edgeR and DESeq2 (with interaction model), Z-score method and
Babel on simulated data with large difference between dispersions of RF and RNA-Seq counts (see also Supplementary Figure S-4). (C) Comparison of the
distribution of TE ratios of genes that were detected to have a significant change in translation efficiency by RiboDiff (w/ joint dispersion), Z-score based
analysis and Babel. DESeq2 was very similar to RiboDiff (w/ joint dispersion) and was omitted. Data was taken from GEO accession GSE56887.
the expressions governing the expected RNA-Seq and RF counts. It can be
considered to be a proxy for shared transcriptional/translation activity under
condition C in this context. Then, βi
∆,C indicates the deviation from that
activity under condition C, with βi
∆,C = 0 for C = 0 and free otherwise
(See Supplemental Section B for more details).
Fitting the GLM consists of learning the parameters βi and dispersions
κi given mRNA and RF counts for the two conditions C = {0, 1}. We
perform alternating optimization of the parameters βi given dispersions κi
and the dispersion parameters κi given βi, similar to the EM algorithm
(Supplemental Sections B and C):
βi = argmax
βi
ℓglm(β
i|yi, κi) and κi = argmax
κi
ℓNB(κ
i|yi, µi).
As experimental procedures for measuring mRNA counts and RF counts
differ, we enable the estimating of separate dispersion parameters for the data
sources of RNA-Seq and RF profiling to account for different characteristics
(Supplemental Section E).
As in Anders et al. (2012), with raw dispersions estimated from previous
steps, we regress all κi given the mean counts to obtain a mean-dispersion
relationship f(µ) = λ1/µ + λ0. We perform empirical Bayes shrinkage
(Love et al., 2014) to shrink κi towards f(µ) to stabilize estimates (see
Supplemental Section D). The proposed model in RiboDiff with a joint
dispersion estimate is conceptually identical to using the following GLM
design matrix protocol+condition+condition : protocol (for instance,
in conjunction with edgeR or DESeq1/2).
In a treatment/control setting, we can then evaluate whether a treatment
(C = 1) has a significant differential effect on translation efficiency
compared to the control (C = 0). This is equivalent to determining whether
the parameter β∆,1 differs significantly from 0 and whether the relationship
denoted by the dashed arrow in Fig. 1A is needed or not. We can compute
significance levels based on the χ2 distribution by analyzing log-likelihood
ratios of the Null model (βi
∆,1 = 0) and the alternative model (β
i
∆,1 6= 0).
3 RESULTS AND DISCUSSION
We simulated data with different dispersions applied to mRNA
and RF counts (see Supplemental Section F). We illustrate the
performance of our method RiboDiff (with separate dispersion
estimates) as well as Babel and the Z-score method. Although
conceptually closely related to RiboDiff with joint dispersion
estimates, we also include DESeq2 and edgeR with a GLM
that includes an interaction term (GLM condition + protocol +
condition : protocol) to model RNA-seq and RF counts. Figure 1B
shows the receiver operating characteristic (ROC) curve for a case
with large dispersion differences between RF and RNA-seq counts.
RiboDiff exhibits a superior detection accuracy compared to edgeR,
DESeq2, Babel and Z-score method, which is less pronounced when
RF and RNA-Seq dispersions are more similar (see Supplementary
Figure S-4). We obtained close to identical results for RiboDiff with
joint dispersion and DESeq2 with interaction term, although edgeR
with the same setting is slightly better than RiboDiff with joint
dispersion (data not shown). Our experiments illustrate that it can
be beneficial to use the RiboDiff model with separate dispersions,
in particular, when the dispersions of RF and RNA-seq data differ
considerably.
We also re-analyzed previously released ribosome footprint data
(GEO accession GSE56887). After multiple testing correction,
RiboDiff detected 601 TE down-regulated genes and 541 up-
regulated ones with FDR ≤ 0.05, which is about twice as many
as reported previously. The new significant TE change set includes
more than 90% genes identified in the previous study. RiboDiff is
also compared to Z-score method and we find major differences (see
Fig. 1C). Supplemental Section G provides the evidences showing
that the Z-score based method is biased towards genes with low
read count, whereas RiboDiff identifies more plausible differences.
Babel identifies only very few genes with differential TE. We ran the
differential test of RiboDiff on a machine with 1.7 GHz CPU and
4GB RAM, it took 23mins of computing time to finish (10, 474
genes having both mRNA and RF counts).
In summary, we propose a novel statistical model to analyze the
effect of the treatment on mRNA translation and to identify genes of
differential translation efficiency. A major advantage of this method
is facilitating comparisons of RF abundance by taking mRNA
abundance variability as a confounding factor. Moreover, RiboDiff
is specifically tailored to produce robust dispersion estimates for
different sequencing protocols measuring gene expression and
ribosome occupancy that have different statistical properties. The
described approach is statistically sound and identifies a similar set
of genes from a less developed method that was used in recent work
Wolfe et al. (2014). The release of this tool is expected to enable
proper analyses of data from many future RF profiling experiments
(e.g. Su et al., 2015). The described model assumes that RNA-seq
2
and RF samples are unpaired and it is future work to extend the
flexibility of the tool to a broader range of experimental settings.
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